| Net Income Per Share |
Net Income Per Share The following table presents the Company’s basic net income per share (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2023 | | 2022 | | 2023 | | 2022 | | Net income per share, basic: | | | | | | | | | Net income | $ | 14,380 | | | $ | 13,110 | | | $ | 19,391 | | | $ | 21,527 | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted average shares of Class A and Class B common stock outstanding | 100,212 | | | 116,791 | | | 102,225 | | | 117,774 | | | Net income per share, basic | $ | 0.14 | | | $ | 0.11 | | | $ | 0.19 | | | $ | 0.18 | |
The following table presents the Company’s diluted net income per share (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2023 | | 2022 | | 2023 | | 2022 | | Net income per share, diluted: | | | | | | | | | Numerator: | | | | | | | | | Net income | $ | 14,380 | | | $ | 13,110 | | | $ | 19,391 | | | $ | 21,527 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Denominator: | | | | | | | | | Weighted average shares of Class A and Class B common stock outstanding, basic | 100,212 | | | 116,791 | | | 102,225 | | | 117,774 | | | Effect of dilutive securities: | | | | | | | | | Options to purchase common stock | 4,877 | | | 7,165 | | | 5,111 | | | 7,563 | | | | | | | | | | | Unvested restricted stock units | 330 | | | 135 | | | 351 | | | 210 | | | Employee stock purchase plan | — | | | — | | | 3 | | | — | | | | | | | | | | | Weighted average shares of Class A and Class B common stock outstanding, diluted | 105,419 | | | 124,091 | | | 107,690 | | | 125,547 | | | Net income per share, diluted | $ | 0.14 | | | $ | 0.11 | | | $ | 0.18 | | | $ | 0.17 | |
The following table presents the weighted average number of potentially dilutive common stock equivalents excluded from the computation of diluted net income per share because their inclusion would have been anti-dilutive (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2023 | | 2022 | | 2023 | | 2022 | | Options to purchase common stock | 5 | | | 66 | | | 3 | | | 64 | | | Unvested restricted stock units | 6,536 | | | 6,276 | | | 6,163 | | | 5,567 | | | | | | | | | | | | | | | | | | | | | | | | | | | Employee stock purchase plan | 185 | | | 170 | | | 141 | | | 197 | | | Total shares excluded from diluted net income per share | 6,726 | | | 6,512 | | | 6,307 | | | 5,828 | |
In April 2021, the Company granted a restricted stock unit (“RSU”) award (the “CEO Performance Award”), which included service, market, and performance based vesting conditions. The CEO Performance Award is excluded from the above table because none of the market conditions have been met as of June 30, 2023.
|